Strand Life Sciences

Strand Life Sciences Pvt Ltd. is a clinical diagnostics and genomic profiling company based in Bengaluru, India, specializing in the development and marketing of diagnostic tests for cancer and inherited diseases. Founded in 2000, the company offers a wide range of services, including diagnostics for oncology, genetics, fertility, women's health, infectious diseases, and general wellness. Strand provides advanced bioinformatics solutions, such as variant curation and interpretation platforms, along with its StrandOmics software for actionable insights from genomic data. The firm operates a DNA sequencing lab and has established partnerships with over 100 hospitals in India, expanding its reach into the US market. Strand's innovative software, including GeneSpring and Avadis, is utilized by 1,400 research institutions worldwide. The company emphasizes personalized medicine by identifying hereditary cancer risks and enabling tailored surveillance and risk-reduction strategies for patients. With a team of approximately 200 employees, Strand Life Sciences continues to grow in response to increasing demand for its genomic testing and interpretation services.

Karishma Maini

Vice President, Clinical Business

Prabhakar Rajagopal Ph.D

Senior Vice President, Biodiversity Informatics and Director

2 past transactions

Quest Diagnostics India

Acquisition in 2018
Quest Diagnostics India is a leading provider of pathology and clinical laboratory testing services, offering critical diagnostic insights that assist healthcare professionals in making informed decisions. The company conducts a wide range of tests, including cancer diagnostics and infectious disease testing, such as for the chikungunya virus. Its central laboratory, located in Gurugram, Delhi, plays a key role in facilitating clinical trials and advancing healthcare solutions. By continuously innovating and enhancing its testing capabilities, Quest Diagnostics India maintains a strong reputation in the clinical laboratory sector, ensuring reliable health information for millions of patients and their families each year. The company collaborates with academic institutions, pharmaceutical and biotechnology firms, and medical technology companies to drive technical advancements in diagnostics.

Triesta Sciences

Acquisition in 2018
Triesta Sciences Inc. specializes in molecular diagnostic services for oncology, offering comprehensive solutions for cancer diagnostics and genomic biomarker research. Established in 2002 and based in Bengaluru, India, the company provides laboratory testing services that encompass areas such as pharmacology, toxicology, immunology, biochemistry, microbiology, and viral serology. Additionally, Triesta Sciences supports pharmaceutical and biotechnology companies with research and development services, including clinical trial management and biomarker discovery and validation. As a subsidiary of Strand Life Sciences Pvt Ltd since 2018, Triesta Sciences aims to deliver advanced pathology services to public hospitals, private pathology practices, specialist medical practitioners, and healthcare organizations.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.